Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anti-hyperlipidemic drug].

N Nakaya1

  • 1Tokyo Metropolitan National Health Insurance Organization, Fussa Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 3, 1999
PubMed
Summary

This review outlines drug treatments for hyperlipidemia, detailing lipid-lowering agents and therapeutic strategies. It recommends statins for hypercholesterolemia and fibrates for combined hyperlipidemia, with combination therapies for severe or resistant cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship between the housing coldness/warmth evaluation by CASBEE Housing Health Checklist and psychological distress based on TMM Community-Based Cohort Study: a cross-sectional analysis.

Public health·2022
Same author

Coffee consumption and mortality in Japan with 18 years of follow-up: the Jichi Medical School Cohort Study.

Public health·2021
Same author

Omega-3 polyunsaturated fatty acids and psychological intervention for workers with mild to moderate depression: A double-blind randomized controlled trial.

Journal of affective disorders·2018
Same author

Unemployment risk among individuals undergoing medical treatment for chronic diseases.

Occupational medicine (Oxford, England)·2015
Same author

Personality and suicide risk: the impact of economic crisis in Japan.

Psychological medicine·2014
Same author

Clinical biopsychosocial risk factors for depression in lung cancer patients: a comprehensive analysis using data from the Lung Cancer Database Project.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Metabolic Disorders

Context:

  • Hyperlipidemia poses a significant risk for cardiovascular diseases.
  • Effective management of lipid disorders is crucial for patient outcomes.
  • Current therapeutic guidelines evolve with new pharmacological data.

Purpose:

  • To review the mode of action, efficacy, and safety of various lipid-lowering agents.
  • To describe evidence-based strategies for treating hyperlipidemia.
  • To provide guidance on drug selection and combination therapy for different lipid profiles.

Summary:

  • For hypercholesterolemia, statins are first-line, with additions like cholestimide, nicotinic acid, or probucol if needed.
  • Mild hypertriglyceridemia may respond to dextran sulfate sodium or low-dose fibrates (fenofibrate, bezafibrate).
  • Severe hypertriglyceridemia and combined hyperlipidemia require combination therapy, often involving fibrates, nicotinic acid, ethyl icosapentate, or statins based on specific lipid levels.

Impact:

  • Informs clinicians on optimal drug choices for managing hyperlipidemia.
  • Supports personalized treatment approaches based on patient lipid profiles.
  • Contributes to the understanding of pharmacological interventions for dyslipidemia.

Related Experiment Videos